BioCentury
ARTICLE | Financial News

Stemline completes follow-on

January 12, 2015 8:00 AM UTC

Stemline Therapeutics Inc. (NASDAQ:STML), New York, N.Y. Business: Cancer Date completed: 2015-01-08 Type: Follow-on Raised: $59.9 million Shares: 3.8 million Price: $15.75 Shares after offering: 17.1...